Next-generation RSV vaccines avoid flipping out.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 36542695.
- Also identified by DOI 10.1126/scitranslmed.ade9984.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In clinical trials, RSV prefusion F protein induced higher neutralizing antibodies and more activated memory B cells than postfusion F protein (Chang <i>et al.</i>).
Medical subject headings
- Respiratory Syncytial Virus Vaccines
- Respiratory Syncytial Virus Infections
- Respiratory Syncytial Virus, Human